Erythropoietin and engineered innate repair activators

Methods in Molecular Biology

Volumn 982, Issue , 2013, Pages 1-11

  Brines, Michael ^a   Cerami, Anthony ^a  

^a ARAIM PHARMACEUTICALS   (United States)

Author keywords

Drug design; Healing; Inflammation; Innate immune response; Tissue damage; Tissue protection; Type 1 cytokine

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ACUTE DISEASE; ARTICLE; CHRONIC DISEASE; DRUG DESIGN; DRUG EFFECT; DRUG STRUCTURE; HUMAN; INJURY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; THROMBOSIS; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM;

ANIMALS; ERYTHROPOIETIN; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ERYTHROPOIETIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84883469904     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-308-4_1     Document Type: Article

References (28)

1. Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78: 183-205
2. Marti HH, Wenger RH, Rivas LA et al (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676
3. Westenfelder C, Biddle DL, Baranowski RL (1999) Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820
4. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269: 19488-19493
5. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116
6. Brines ML, Ghezzi P, Keenan S et al (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97: 10526-10531
7. Erbayraktar S, Grasso G, Sfacteria A et al (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 100: 6741-6746
8. Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228: 1-14
9. Pinto JP, Ribeiro S, Pontes H et al (2008) Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 111: 5727-5733
10. Brines M, Cerami A (2008) Erythropoietinmediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 264: 405-432
11. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87: 5978-5982
12. Masuda S, Nagao M, Takahata K et al (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268: 11208-11216
13. Imai N, Higuchi M, Kawamura A et al (1990) Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro. Eur J Biochem 194: 457-462
14. Cheetham JC, Smith DM, Aoki KH et al (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol 5: 861-866
15. Leist M, Ghezzi P, Grasso G et al (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242
16. Brines M, Grasso G, Fiordaliso F et al (2004) Erythropoietin mediates tissue protection through an erythropoietin and common betasubunit heteroreceptor. Proc Natl Acad Sci U S A 101: 14907-14912
17. Lopez AF, Hercus TR, Ekert P et al (2010) Molecular basis of cytokine receptor activation. IUBMB Life 62: 509-518
18. Jubinsky PT, Krijanovski OI, Nathan DG, Tavernier J, Sieff CA (1997) The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90: 1867-1873
19. Brines M, Cerami A (2012) The receptor that tames the innate immune response. Mol Med 18(1): 486-496
20. Corwin HL, Gettinger A, Fabian TC et al (2007) Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357: 965-976
21. Brines M, Patel NS, Villa P et al (2008) Non erythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 105: 10925-10930
22. Nogawa-Kosaka N, Hirose T, Kosaka N et al (2010) Structural and biological properties of erythropoietin in Xenopus laevis. Exp Hematol 38: 363-372
23. Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609: 29-35
24. Mahmood A, Lu D, Qu C et al (2007) Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg 107: 392-397
25. van der Meer P, Lipsic E, Henning RH et al (2005) Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46: 125-133
26. Erbayraktar Z, Erbayraktar S, Yilmaz O, Cerami A, Coleman T, Brines M (2009) Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol Med 15: 235-241
27. Su KH, Shyue SK, Kou YR et al (2011) Beta common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J Cell Physiol 226(12): 3330-3339
28. Sautina L, Sautin Y, Beem E et al (2010) Induction of nitric oxide by erythropoietin is mediated by the beta common receptor and requires interaction with VEGF receptor 2. Blood 115: 896-905